Search results
Merck's Keytruda combo gets FDA nod for expanded use in cervical cancer
Reuters via Yahoo News· 4 months agoThe Keytruda combination was approved for patients with cervical cancer who had not previously...
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 1 year agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Immunotherapy drugs helps in fight against cancer, explains Savannah doctor
Savannah Morning News via Yahoo News· 7 months agoImmunotherapy is a recent addition to the arsenal of weapons used against cancer. A Savannah area...
Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use
Zacks via Yahoo Finance· 2 years agoMerck's (MRK) anti-PD-1 therapy Keytruda nears potential approval as an adjuvant treatment for...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 2 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Reuters via Yahoo Finance· 1 year agoAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or...
Merck profit tops Wall Street view on strong Keytruda sales
Reuters via Yahoo Finance· 2 years ago(Reuters) -Merck & Co on Thursday reported higher-than-expected second-quarter earnings and revenue...
Merck seeks more deals to prepare for Keytruda's revenue decline
Reuters via Yahoo Finance· 3 months ago(Reuters) -Merck & Co on Thursday said it was in the market for deals of up to around $15 billion as...
AstraZeneca's (AZN) Imfinzi/Imjudo Combo Gets Another FDA Nod
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN announced that the FDA approveda dual immunotherapy regimen consisting of PD-L1...